一种用于质瘤向药物输送的新型类药物联合体
Jianfen Zhou1, Nana Meng1, Linwei Lu2
1Department of Pharmaceutics, School of Pharmacy, Fudan University & Key Laboratory of Smart Drug Delivery (Fudan University), Ministry of Education and PLA, Shanghai 201203, China.
概括
一种新型的类药物结合物有效地穿越血脑和瘤屏障,向质瘤细胞. 这一突破提高了化疗的治疗效果,降低了毒性,并在临床前模型中改善了生存率.
科学领域:
- 神经科学是一个神经科学.
- 在瘤学瘤学.
- 生物医学工程 生物医学工程
背景情况:
- 血脑屏障 (BBB) 和血脑瘤屏障 (BBTB) 阻碍了有效的质瘤化疗.
- 有针对性的药物输送系统对于克服这些障碍和最大限度地减少系统毒性至关重要.
研究的目的:
- 开发一种最佳的药物递送系统,能够穿越BBB/BBTB并向质瘤细胞.
- 合成和评估一种新型的类药物合物,用于增强质瘤治疗.
主要方法:
- 在质瘤组织和BBB上确定了高表达的葡萄糖调节蛋白78 (GRP78) 和多巴胺受体.
- 合成了一种新的"Y"形,并优化其链接器以获得受体亲和力.
- 开发了一种类药物合物 (pHA-AOHX-VAP-doxorubicin) 用于质瘤治疗.
主要成果:
- 合物pHA-AOHX-VAP-DOX对质瘤细胞的亲和力增强,可溶性改善.
- 结合物通过多巴胺和GRP78受体成功地穿越了BBB和BBTB.
- 在患有内质瘤的小鼠中观察到显著延长生存时间,同时减少了多克索鲁比辛的毒性和增加了最大耐受剂量.
结论:
- 这项研究提出了一种克服BBB/BBTB的新策略,为质瘤提供化疗药物.
- 开发的类药物合物显示出对有效和更安全的质瘤治疗的承诺.
- 确定了GRP78和多巴胺受体作为未来质瘤向药物输送系统的潜在目标.
更多相关视频
07:25Author Spotlight: Multimodal Imaging Strategies for Optimizing Drug Delivery and Early Detection in Glioblastoma Treatment
Published on: March 1, 2024
2.3K
09:02Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
Published on: September 27, 2024
2.5K
相关概念视频
01:24Modified-Release Drug Delivery Systems: Site-Targeted
164
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
164
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
160
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
160